Autoantibodies as Potential Biomarkers in Breast Cancer
AbstractBreast cancer is a major cause of mortality in women; however, technologies for early stage screening and diagnosis (e.g., mammography and other imaging technologies) are not optimal for the accurate detection of cancer. This creates demand for a more effective diagnostic means to replace or be complementary to existing technologies for early discovery of breast cancer. Cancer neoantigens could reflect tumorigenesis, but they are hardly detectable at the early stage. Autoantibodies, however, are biologically amplified and hence may be measurable early on, making them promising biomarkers to discriminate breast cancer from healthy tissue accurately. In this review, we summarized the recent findings of breast cancer specific antigens and autoantibodies, which may be useful in early detection, disease stratification, and monitoring of treatment responses of breast cancer. View Full-Text
Share & Cite This Article
Qiu, J.; Keyser, B.; Lin, Z.-T.; Wu, T. Autoantibodies as Potential Biomarkers in Breast Cancer. Biosensors 2018, 8, 67.
Qiu J, Keyser B, Lin Z-T, Wu T. Autoantibodies as Potential Biomarkers in Breast Cancer. Biosensors. 2018; 8(3):67.Chicago/Turabian Style
Qiu, Jingyi; Keyser, Bailey; Lin, Zuan-Tao; Wu, Tianfu. 2018. "Autoantibodies as Potential Biomarkers in Breast Cancer." Biosensors 8, no. 3: 67.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.